| Schedule of share capital |
| | | | | | | Number of ordinary shares | | | Year ended | | Year ended | | | 30 June 2026 | | 30 June 2025 | Balance at beginning of year | | 139,438,971 | | 109,832,217 | Expenses settled in shares | | — | | 170,000 | Shares issued in relation to acquisition | | — | | 150,000 | Issued for cash | | 55,369,010 | | 29,286,754 | In issue at 30 June – fully paid (par value 1.0p) | | 194,807,981 | | 139,438,971 |
| | | | | | | Ordinary share capital | | | Year ended | | Year ended | | | 30 June 2026 | | 30 June 2025 | | | US$’000 | | US$’000 | Balance at beginning of year | | 1,739 | | 1,346 | Expenses settled in shares | | — | | 2 | Shares issued in relation to acquisition | | — | | 2 | Share issues | | 743 | | 389 | Balance at end of year | | 2,482 | | 1,739 |
16.Share capital (continued) | | | | | | | Share premium | | | Year ended | | Year ended | | | 30 June 2026 | | 30 June 2025 | | | US$’000 | | US$’000 | Balance at beginning of year | | 17,557 | | 9,680 | Expenses settled in shares | | — | | 61 | Shares issued in relation to acquisition | | — | | 63 | Share issues | | 89,643 | | 7,882 | Expenses relating to share issues | | (6,388) | | (129) | Balance at 30 June | | 100,812 | | 17,557 |
|